NASDAQ:VRAX

Virax Biolabs Stock Faces a Make-or-Break Nasdaq Vote After a Wild Week
····

Virax Biolabs Stock Faces a Make-or-Break Nasdaq Vote After a Wild Week

Virax closed Friday at $0.2775, down 9.31%, but up 81% from May 15. Shareholders will vote June 5 on a 10-for-1 to 30-for-1 reverse share consolidation as the company faces a July 11 Nasdaq deadline to regain $1 minimum bid compliance. U.S. markets are closed Monday for Memorial Day, with trading to resume Tuesday. Armistice Capital disclosed a 4.99% stake in Virax earlier this month.
May 25, 2026

Stock Market Today

  • Top 2 ASX Shares to Buy and Hold for the Next Decade
    May 29, 2026, 8:30 PM EDT. Two ASX shares stand out for long-term growth potential: Lovisa Holdings Ltd (ASX: LOV) and the Global X S&P World Ex Australia GARP ETF (ASX: GARP). Lovisa, a fast-growing affordable jewellery retailer, is expanding its global footprint with a 6.3% store increase recently, boosted by strong 20% revenue and profit growth. Its valuation stands at under 19 times estimated FY28 earnings per share, signaling potential value. Meanwhile, the GARP ETF invests in 250 global companies with growth-at-a-reasonable-price traits, targeting firms with solid sales, earnings, attractive price/earnings ratios, and strong financial quality, positioning it for potential market-beating returns. These choices reflect solid growth and value strategies aimed at outperforming the S&P/ASX 200 Index over the next decade.